Target intelligence / Profile preview

Janus kinase family (JAK)

Target
JAK
Molecular classification
Non-receptor tyrosine kinase, Protein kinase, Enzyme family
01

Overview

The Janus kinase family (JAK) is a group of non-receptor tyrosine kinases that play crucial roles in cytokine signaling and immune regulation. The family consists of four members: JAK1, JAK2, JAK3, and TYK2. They are named after the two-faced Roman god Janus, reflecting their structure with two near-identical phosphate-transferring domains: one active kinase domain (JH1) and a pseudokinase domain (JH2) that regulates activity. JAKs range from 120-140 kDa and have seven homology domains (JH1-7), including a FERM domain (JH4-JH7) that mediates association with cytokine receptors. JAKs are constitutively associated with the intracellular domains of type I and type II cytokine receptors. They function as signal transducers in the JAK-STAT pathway; upon cytokine binding to receptors, JAKs are activated, phosphorylate the receptors, and create docking sites for signaling molecules, especially STATs, ultimately driving gene transcription.

Other names
JAK1JAK2JAK3TYK2just another kinase 1just another kinase 2
02

Mechanism of action

JAK inhibitors block cytokine signaling by inhibiting one or more JAK enzymes, thereby interfering with the JAK-STAT signaling pathway in lymphocytes.

03

Biological functions

Cytokine signalingImmune regulationSignal transduction via JAK-STAT pathwayAssociation with cytokine receptorsReceptor phosphorylationSTAT protein activationRegulation of gene transcription
04

Disease associations

Immunological disorders (e.g., Severe combined immunodeficiency, HyperIgE syndrome)Myeloproliferative disorders (e.g., Polycythemia vera, Essential thrombocytosis, Primary myelofibrosis)Inflammatory conditions (e.g., Pruritic dermatitis, Allergic rhinitis, Asthma, Inflammatory bowel disease)Autoimmune conditions (e.g., Rheumatoid arthritis, Psoriasis)
05

Interacting drugs

Abrocitinib

10 more in the full profile.

Beyond the preview

Go deeper on Janus kinase family (JAK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Janus kinase family (JAK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call